Sometimes, authors and journals editors seem to think a bit of mystery is a good thing. Take a recent retraction in Brain.
Here’s the notice for “Selective impairment of hand mental rotation in patients with focal hand dystonia:” Continue reading “Ambiguities in the presentation of some of the data” lead to an ambiguous retraction notice
Talk about a Trojan Horse.
Biochemical and Biophysical Research Communications has withdrawn a paper it published earlier this year on metabolic proteins linked to diabetes, not because the article was bogus but because the authors appear to have been. The work itself is accurate — indeed, it likely belongs to a Harvard scientist, Bruce Spiegelman, who’d presented his data on the subject several times recently and was in the process of preparing his results for publication. We’ve written about researchers trying to punk journals with faked articles, and about a researcher who apparently made up a co-author, but here’s something new!
Nature has the story. According to Nature, in July Spiegelman: Continue reading Journal withdraws diabetes paper written by apparently bogus authors
The Journal of of Inequalities and Applications has retracted a paper for unspecified “ethical problems.”
Here’s the notice for “Strong Limiting Behavior in Binary Search Trees:” Continue reading Math paper retracted because it “contains some ethical problems”
Rakesh Kumar, a professor at the George Washington University, has retracted a paper in the Journal of Biological Chemistry (JBC) that was recently questioned on PubPeer.
Here are Peer1’s comments from PubPeer about the paper, “Mechanism of MTA1 Protein Overexpression-linked Invasion:” Continue reading Author with six recent corrections retracts JBC paper questioned on PubPeer
The corresponding author of a paper on whether “a sense of shame heightens the desire for money” has retracted it, he claims, after being unable to repeat his analysis to try to fix an issue in the study.
Here’s the notice for “Shame for money: Shame enhances the incentive value of economic resources,” which appeared in Judgment and Decision Making: Continue reading A real shame: Psychology paper retracted when data behind problematic findings disappear
An assistant professor of neuroscience at Tufts has withdrawn a paper published last year after one round of corrections wasn’t enough to fix all of the study’s problems.
The study, “Sirtuin 2 (SIRT2) enhances 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced nigrostriatal damage via deacetylating forkhead box O3a (Foxo3a) and activating Bim protein,” by Gizem Donmez and colleagues, had already been subject to an extensive correction in May: Continue reading Authors withdraw already-corrected JBC paper questioned on PubPeer
An Australian university has put a hold on trials of an experimental drug for skin cancer whose main developer has been dogged by charges of research misconduct for several years.
The Australian Broadcasting Corporation is reporting that the University of New South Wales has suspended trials of the drug, DZ13, while it investigates the work of Levon Khachigian, who is leading the studies.
According to the news organization, Khachigian and his group were cleared by the school in two prior inquiries. However, additional accusations of misconduct — specifically involving image manipulation and misuse — prompted a third investigation.
We’ve found four retractions of Khachigian’s studies, from the Journal of Biological Chemistry and Biochemical and Biophysical Research Communications, between 2009 and 2010 (before the launch of Retraction Watch).
When you think of an administrative error, what comes to mind? Failure to tell an employee that the reason he didn’t receive a paycheck in July was because he was fired in June? Putting the wrong address on your business cards?
You’d probably have to go pretty far down the list before you reached something like this: “I used text from one of my previously published articles in a second paper.” And yet … Continue reading “Administrative error on the part of the author” that led to duplicated text prompts retraction
A PhD student at the University of Virginia’s Darden School of Business who had a paper retracted for plagiarism in March has had a second paper retracted.
Bloomberg BusinessWeek was first to report the new retraction by Eugene Z. Geh. The study, “Understanding the Antecedents to an Entrepreneurial Firm’s Intent to Engage in International Strategic Alliances,” originally published in the Journal of Enterprising Culture, now simply reads: Continue reading University of Virginia business PhD student has second paper retracted
A group of authors has withdrawn a paper from the Journal of Biological Chemistry (JBC), but readers won’t know why.
The paper, “Static High-Gradient Magnetic Fields Activate Transient Receptor Potential Vanilloid 4 (TRPV4) Ion Channels Enabling Remote Control of Cell Function,” whose corresponding author is Thomas Simmet of Ulm University, appeared online on June 11. Since June 24, the PDF of the paper has been stamped: Continue reading Researchers get a mulligan: JBC paper withdrawn sans explanation